Global Ganja Report

In a blow to municipal power to regulate medical marijuana, the US Supreme Court on March 21 refused to hear Oakland's appeal of last year's ruling by the 9th Circuit Court of Appeals that the city cannot help defend Harborside Health Center in federal court. The Justice Department has been trying to shut down the flagship dispensary on the Oakland waterfront—dubbed a "superstore" by US attorney Melinda Haag. The city of Oakland tried to intervene in the case, asserting that Harborside's closure would rob the cash-strapped municipality of millions in tax revenues.

It takes a strong stomach to wade through the relentless parade of horror that is A Narco History. But if you really want to grasp "How the United States and Mexico Jointly Created the 'Mexican Drug War'," as the subtitle promises—this is the book to read...

Co-authors Carmen Boullosa and Mike Wallace open with a chillingly detailed depiction of the grisly end met by 43 student protesters in Guerrero state, who were in September 2014 abducted by police and turned over to a mass-murdering narco-gang. What authorities believe to be their burnt remains were left in garbage bags at the bottom of a canyon.

Members of the Confederated Tribes of Warm Springs, on the eastern slopes of Oregon's Cascade Mountains, voted up a proposal to permit growing, processing and selling cannabis for the recreational market, tribal officials announced Dec. 18. The referendum passed by an impressive 86%, said Don Sampson, CEO of Warm Springs Ventures, the tribes' economic development corporation. Sampson told The Oregonian that the election drew about 1,400 voters who "turned out even in a winter storm." Turnout among youth was especially strong.

Philadelphia Inquirer columnist Chris Goldstein got hold of a leaked 45-page internal equity report from high-finance titan Merrill Lynch, wealth management division of Bank of America, looking at the future prospects for America's cannabis industry. Goldstein wrote it up for his occassional series Philly420 Dec. 8 under the title "Merrill Lynch is bullish on marijuana." Goldstein finds: "Carefully researched, it was an interesting peek at how heavy hitters on Wall Street are starting to view the expanding industry."

There have been quite a few histories of cannabis culture and politics, but Bruce Barcott's Weed The People: The Future of Legal Marijuana in America is the first to examine the cannabis industry and its future prospects at a moment when it is taking flight. His opening overview of how we got to this point is engaging if not always strictly accurate (he loans too much credence to the '70s paraquat scare). He notes the litany of US government reports back to the 1920s exculpating cannabis of the calumnies against it—all ignored by the very government that commissioned them. He details the bureaucratic obstacles that have been raised to research on cannabis' medical benefits. And he relates the passing of the torch (or, more literally, the joint) from the jazz scene to the beatniks to the hippies to the mainstream.

Voters in Ohio on Nov. 3 rejected a proposal to legalize medical and recreational use of cannabis. Issue 3 would have allowed adults 21 and older to use, purchase or grow regulated quantities, and also made cannabis available for medical use in the same vote—a unique approach nationally. It would additionally have permitted retail sale of cannabis-infused products, and created a "Marijuana Control Commission" to oversee the industry. Complicating matters, the Ohio General Assembly put a competing initiative on the ballot, Issue 2, which would have blocked Issue 3 by prohibiting the granting of special rights by the state constitution. This "anti-monopoly measure" was aimed at barring Issue 3 language that would establish exclusive rights to produce cannabis for the retail market. If both had passed, a legal quagmire loomed. In the actual fact, Issue 2 was approved while Issue 3 was defeated by over 63% of voters. (Jurist, Nov. 4; WLWT, Cincinnnati, Nov. 3; NYT, Nov. 1)

Uruguay's government announced Oct. 1 the granting of licenses to two companies to grow cannabis for commercial distribution. Juan Andrés Roballo, head of the National Drug Board, said the two companies chosen out of 22 applicants were Symbiosys and Iccorp, both start-ups financed by Uruguayan and foreign capital. They will each be allowed to produce two metric tons of cannabis yearly—with the plantations to be guarded by government troops. Uruguayans will be able to purchase 10 grams (about a third of an ounce) weekly. Roballo told reporters that cannabis will go on sale in the country's  pharmacies "in no less than eight months from now."

On Sept. 11, the California state legislature approved a trio of bills to establish comprehensive regulation and licensing of medical cannabis. Assembly Bills 243 and 266 and Senate Bill 643 were all passed, and will delegate regulation of commercial medical cannabis cultivation, manufacturing, transportation, and distribution to various state agencies as well as create a state-level licensing system. Gov. Jerry Brown is widely expected to sign all three pieces of legislation. "We're glad the legislature has finally been able to move forward on regulations," said Don Duncan, California direcotr of Americans for Safe Access (ASA). "History has shown that regulation can improve community outcomes while still preserving patient access. Passing medical cannabis regulation before the state moves forward with a potential adult-use recreational system next year is extremely important for the preservation of the medical cannabis program.”